Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Aspects of Invasiveness of Ludwigia and Nelumbo in Shallow Temperate Fluvial Lakes.

Tóth VR, Villa P, Pinardi M, Bresciani M.

Front Plant Sci. 2019 May 16;10:647. doi: 10.3389/fpls.2019.00647. eCollection 2019.

2.

Non-invasive brain stimulation of motor cortex induces embodiment when integrated with virtual reality feedback.

Bassolino M, Franza M, Bello Ruiz J, Pinardi M, Schmidlin T, Stephan MA, Solcà M, Serino A, Blanke O.

Eur J Neurosci. 2018 Apr;47(7):790-799. doi: 10.1111/ejn.13871. Epub 2018 Mar 9.

3.

Coexistence of two species of Leishmania in the digestive tract of the vector Lutzomyia ovallesi.

Barrios M, Rodriguez N, Feliciangeli DM, Ulrich M, Telles S, Pinardi ME, Convit J.

Am J Trop Med Hyg. 1994 Nov;51(5):669-75.

PMID:
7985760
4.

Leprosy in women: characteristics and repercussions.

Ulrich M, Zulueta AM, Cáceres-Dittmar G, Sampson C, Pinardi ME, Rada EM, Aranzazu N.

Soc Sci Med. 1993 Aug;37(4):445-56. Review.

PMID:
8211257
5.

Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results.

Convit J, Sampson C, Zúñiga M, Smith PG, Plata J, Silva J, Molina J, Pinardi ME, Bloom BR, Salgado A.

Lancet. 1992 Feb 22;339(8791):446-50.

PMID:
1346818
6.

Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis.

Convit J, Castellanos PL, Ulrich M, Castés M, Rondón A, Pinardi ME, Rodríquez N, Bloom BR, Formica S, Valecillos L, et al.

J Infect Dis. 1989 Jul;160(1):104-15.

PMID:
2659679
7.

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.

Convit J, Castellanos PL, Rondon A, Pinardi ME, Ulrich M, Castes M, Bloom B, Garcia L.

Lancet. 1987 Feb 21;1(8530):401-5.

PMID:
2880213
8.

The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis.

Convit J, Ulrich M, Aranzazu N, Castellanos PL, Pinardi ME, Reyes O.

Lepr Rev. 1986 Dec;57 Suppl 2:263-73. No abstract available.

PMID:
3553799
9.

Immunotherapy and immunoprophylaxis of leprosy.

Convit J, Aranzazu N, Zúñiga M, Ulrich M, Pinardi ME, Castellazzi Z, Alvarado J.

Lepr Rev. 1983 Jun;Spec No:47-60. Review. No abstract available.

PMID:
6350772
10.

Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.

Convit J, Aranzazu N, Ulrich M, Pinardi ME, Reyes O, Alvarado J.

Int J Lepr Other Mycobact Dis. 1982 Dec;50(4):415-24.

PMID:
6763002
11.

In vitro activation of neutrophils by suspensions of Mycobacterium leprae.

Goihman-Yahr M, Rodriguez-Ochoa G, Aranzazu N, Pinardi ME, de Gomez ME, Ocanto A, Convit J.

Int J Lepr Other Mycobact Dis. 1979 Dec;47(4):570-4.

PMID:
122626
13.

The development of an active vaccine against leprosy.

Convit J, Monzón H, Pinardi ME, Aránzazu N, Ulrich M.

Acta Cient Venez. 1979;30(5):491-3. No abstract available.

PMID:
397704
14.

[Leprosy].

Monzón H, Convit J, de Pinardi ME.

Orthod Fr. 1976;27(5):235-43. Spanish. No abstract available.

PMID:
1071168
16.

Loss of infectivity of mycobacterial and protozoal exoplasmic parasites after exposure in vitro to the polyenzymic cocktail 'PIGO'.

Avila JL, Convit J, Pinardi ME, Jacques PJ.

Biochem Soc Trans. 1976;4(4):680-1. No abstract available.

PMID:
793902
17.

Germicidal activity of a polyenzymic system on pathogenic protozoa in vitro.

Jacques PJ, Avila JL, Pinardi ME, Convit J.

Arch Int Physiol Biochim. 1975 Dec;83(5):976-8. No abstract available.

PMID:
58631
18.

Tests with three antigens in leprosy-endemic and non-endemic areas.

Convit J, Pinardi ME, Rojas FA, Gonzáles I, Corey G, Arvelo JJ, Monzón H.

Bull World Health Organ. 1975;52(2):193-8.

19.

Specificity of the 48-hour reaction to Mitsuda antigen. Use of a soluble antigen from human and armadillo lepromin.

Convit J, Pinardi ME, Avila JL, Aranzazu N.

Bull World Health Organ. 1975;52(2):187-91.

20.

Leprosy: confirmation in the armadillo.

Convit J, Pinardi ME.

Science. 1974 Jun 14;184(4142):1191-2.

PMID:
4133762
21.

Elimination of Mycobacterium leprae subsequent to local in vivo activation of macrophages in lepromatous leprosy by other mycobacteria.

Convit J, Pinardi ME, Rodríguez Ochoa G, Ulrich M, Avila JL, Goihman M.

Clin Exp Immunol. 1974 Jun;17(2):261-5. No abstract available.

22.

Spheroidal bodies and globi of human leprosy.

Barksdale L, Convit J, Kim KS, de Pinardi ME.

Biochem Biophys Res Commun. 1973 Sep 5;54(1):290-6. No abstract available.

PMID:
4582380
23.

A simple method for the differentiation of Mycobacterium leprae from other mycobacteria through routine staining technics.

Convit J, Pinardi ME.

Int J Lepr Other Mycobact Dis. 1972 Apr-Jun;40(2):130-2. No abstract available.

PMID:
4119114
24.

Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host.

Convit J, Pinardi ME, Rondón AJ.

Trans R Soc Trop Med Hyg. 1972;66(4):603-10. No abstract available.

PMID:
5071089
25.

A test for the determination of competency in clearing bacilli in leprosy patients.

Convit J, Avila JL, Goihman M, Pinardi ME.

Bull World Health Organ. 1972;46(6):821-6.

26.

Some considerations regarding the immunology of leprosy.

Convit J, Pinardi ME, Rojas FA.

Int J Lepr Other Mycobact Dis. 1971 Apr-Jun;39(2):556-64. No abstract available.

PMID:
5169815
27.

Immunological reactions in onchocerciasis.

Ulrich M, Pinardi ME, Convit J.

Trans R Soc Trop Med Hyg. 1970;64(1):111-5. No abstract available.

PMID:
5442026
28.

A study of antibody response in leprosy.

Ulrich M, Pinardi ME, Convit J.

Int J Lepr Other Mycobact Dis. 1969 Jan-Mar;37(1):22-7. No abstract available.

PMID:
4980113
29.

Applying the indirect immunofluorescency test to the study of American cutaneous leishmaniasis.

Convit J, Pinardi ME.

Dermatol Int. 1969 Jan-Mar;8(1):17-20. No abstract available.

PMID:
4898831

Supplemental Content

Loading ...
Support Center